VeriMomoligopeptide-106 est-il sûr pendant la grossesse ?
No harmonised CLP classification or SCCS/CIR safety assessment was identified for 'oligopeptide-106', and no peer‑reviewed reproductive toxicity or endocrine‑activity data are available in the major databases. Peptides used in cosmetics are generally high‑molecular‑weight and have low dermal absorption, so there is no evidence of a reproductive hazard under cosmetic use conditions (sources checked: ECHA Annex VI, SCCS/CIR listings, PubMed, CosIng, PubChem).
Related ingredients
Frequently asked questions
- oligopeptide-106 est-il sûr pendant la grossesse ?
- No harmonised CLP classification or SCCS/CIR safety assessment was identified for 'oligopeptide-106', and no peer‑reviewed reproductive toxicity or endocrine‑activity data are available in the major databases. Peptides used in cosmetics are generally high‑molecular‑weight and have low dermal absorption, so there is no evidence of a reproductive hazard under cosmetic use conditions (sources checked: ECHA Annex VI, SCCS/CIR listings, PubMed, CosIng, PubChem).
- oligopeptide-106 est-il sûr pendant l'allaitement ?
- No data indicating reproductive or lactation hazards, no harmonised classification, and no mechanistic evidence for transfer into breast milk or effects on lactation were identified. Given the lack of adverse signals and expected low dermal/systemic absorption of cosmetic peptides, risk is not indicated for breastfeeding (sources checked: ECHA Annex VI, CIR, PubMed, CosIng, PubChem).
- oligopeptide-106 est-il sûr pour la peau de bébé ?
- No hazard or mechanistic data specific to infants were found. Adult dermal absorption is expected to be negligible for oligopeptides used in cosmetics (adult exposure scored 0), but because infant skin has a less mature barrier and higher surface‑area/weight, exposure scoring is increased by +1 to reflect potentially higher, low but measurable exposure in 0–3‑year‑olds. There is no infant‑specific toxicity evidence to increase hazard or mechanism scores (sources checked: CosIng, PubMed, ECHA Annex VI, PubChem).
- Comment VeriMom évalue-t-il oligopeptide-106 ?
- VeriMom évalue oligopeptide-106 à 100/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à oligopeptide-106 pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à oligopeptide-106 basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.